GFAP/UCH-L1 as a Biomarker for Rapid  Assessment of Mild TBI in Emergency Departments

Rakesh Jalali; Marcin Bałuch; Joanna Malinowska; Jacek Zwiernik; Adam Kern; Jacek Bil; Jerzy Romaszko

doi:10.12659/MSM.948353

11 June 2025 : Clinical Research

GFAP/UCH-L1 as a Biomarker for Rapid Assessment of Mild TBI in Emergency Departments

Rakesh Jalali

^{ABCDEFG 1,2*}, Marcin Bałuch

^{BCE 1,2}, Joanna Malinowska

^{BF 1,2}, Jacek Zwiernik

^{BF 3}, Adam Kern

^{BF 4}, Jacek Bil

^{BF 5}, Jerzy Romaszko

^{BF 6}

DOI: 10.12659/MSM.948353

Med Sci Monit 2025; 31:e948353

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 (A) Overall glial fibrillary acid protein (GFAP) and ubiquitin L1 C-terminal hydrolase (UCH-L1) level distribution. (B) CT-negative GFAP and UCH-L1 level distribution. Whiskers show 5–95% CI. A logarithmic scale was used to present results.

Back to the Article

GFAP/UCH-L1 as a Biomarker for Rapid Assessment of Mild TBI in Emergency Departments

Your Privacy